Assessment of pathologic response in the colorectal cancer cohort of the IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Role of RAS/BRAF and PIK3CA mutations in tissue and plasma for prognostic assessment in metastatic colorectal cancer (mCRC).

Dr Hasan picked out four liver cancer warning signs that people should be aware of in order to try and help earlier detection ...

Liver cancer is the sixth most common cancer in the world and the 16th most common in the UK - but it is often detected too ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

Baby JoJo is part of a set of rare identical triplets, but she's fighting liver cancer at just 10 months old. Her cancer ...

January marks Love Your Liver month, prompting a doctor to raise awareness about liver cancer, a condition often detected at ...

Lindén was diagnosed with colon cancer with metastases to the liver.

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

The Phase III trial builds on findings from prior findings that indicated Anktiva can restore T-cell function and improve ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer with disease progression after endocrine therapy.